Do patients with metastatic urothelial carcinoma benefit from docetaxel as second-line chemotherapy?

R. Morales-Barrera, C. Suárez, C. Valverde, I. Nuñez, X. Maldonado, J. Morote, J. Carles

Research output: Contribution to journalArticleResearchpeer-review

8 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Do patients with metastatic urothelial carcinoma benefit from docetaxel as second-line chemotherapy?'. Together they form a unique fingerprint.

Medicine & Life Sciences